The year in heart failure

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 359-368

  Owens, Anjali Tiku ^a   Jessup, Mariell ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

heart failure; transplant; VAD

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTHRACYCLINE ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; EPLERENONE; FUROSEMIDE; GADOLINIUM; INOTROPIC AGENT; IVABRADINE; LOOP DIURETIC AGENT; NESIRITIDE; PATIROMER; PLACEBO; ROLOFYLLINE; SILDENAFIL; TRASTUZUMAB; TROPONIN I; TROPONIN T; UBIDECARENONE;

ACUTE HEART FAILURE; AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; BODY MASS; BRADYCARDIA; CARDIOMYOPATHY; CARDIORENAL SYNDROME; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE URINE LEVEL; DEFIBRILLATOR; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DIURETIC THERAPY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DYSPNEA; GENE THERAPY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE QUALITY; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; HYPERKALEMIA; HYPERTENSION; INHERITANCE; IRON DEFICIENCY; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LOW DRUG DOSE; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; ONSET AGE; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSICAL ACTIVITY; POST TREATMENT SURVIVAL; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SCIENTIFIC LITERATURE; SCORING SYSTEM; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; TREND STUDY; UNITED STATES; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VISUAL DISORDER; WEIGHT GAIN;

EID: 84864206631     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.01.064     Document Type: Review

References (117)

1. K. Dickstein, P.E. Vardas, A. Auricchio 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
2. G. Quarta, A. Muir, A. Pantazis Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria Circulation 123 2011 2701 2709
3. P. Charron, M. Arad, E. Arbustini Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 31 2010 2715 2726
4. M.M. Hannan, S. Husain, F. Mattner Working formulation for the standardization of definitions of infections in patients using ventricular assist devices J Heart Lung Transplant 30 2011 375 384
5. G.J. Berry, A. Angelini, M.M. Burke The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011) J Heart Lung Transplant 30 2011 601 611
6. J. Kobashigawa, M.G. Crespo-Leiro, S.M. Ensminger Report from a consensus conference on antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 2011 252 269
7. S. Husain, M.L. Mooney, L. Danziger-Isakov A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients J Heart Lung Transplant 30 2011 361 374
8. Thygesen K, Mair J, Mueller C, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J. In press.
9. M.J. Ackerman, S.G. Priori, S. Willems HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 2011 1308 1339
10. E.M. Zardi, A. Abbate, D.M. Zardi Cirrhotic cardiomyopathy J Am Coll Cardiol 56 2010 539 549
11. R.E. Hershberger, J.D. Siegfried Update 2011: clinical and genetic issues in familial dilated cardiomyopathy J Am Coll Cardiol 57 2011 1641 1649
12. V.M. Conraads, P.J. Beckers Exercise training in heart failure: practical guidance Heart 96 2010 2025 2031
13. J. Downing, G.J. Balady The role of exercise training in heart failure J Am Coll Cardiol 58 2011 561 569
14. N.M. Hawkins, M.C. Petrie, M.R. Macdonald Heart failure and chronic obstructive pulmonary disease: the quandary of beta-blockers and beta-agonists J Am Coll Cardiol 57 2011 2127 2138
15. B.A. Borlaug, W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur Heart J 32 2011 670 679
16. T. Lahm, C.A. McCaslin, T.C. Wozniak Medical and surgical treatment of acute right ventricular failure J Am Coll Cardiol 56 2010 1435 1446
17. T. Kasai, T.D. Bradley Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications J Am Coll Cardiol 57 2011 119 127
18. K. Stergiopoulos, E. Shiang, T. Bench Pregnancy in patients with pre-existing cardiomyopathies J Am Coll Cardiol 58 2011 337 350
19. L. Bettari, M. Fiuzat, R. Becker, G.M. Felker, M. Metra, C.M. O'Connor Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions Circ Heart Fail 4 2011 361 368
20. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, G.M. Felker Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
21. C.M. O'Connor, R.C. Starling, A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
22. W.T. Abraham, P.B. Adamson, R.C. Bourge Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
23. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
24. F. Zannad, J.J. McMurray, H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
25. B. Pitt, S.D. Anker, D.A. Bushinsky, D.W. Kitzman, F. Zannad, I.Z. Huang Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial Eur Heart J 32 2011 820 828
26. A.S. Tang, G.A. Wells, M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
27. K. Swedberg, M. Komajda, M. Bohm Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
28. K.A. Ellenbogen, M.R. Gold, T.E. Meyer Primary results from the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy Circulation 122 2010 2660 2668
29. D. Lloyd-Jones, R.J. Adams, T.M. Brown Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
30. A. Kalogeropoulos, B.M. Psaty, R.S. Vasan Validation of the Health ABC Heart Failure Model for incident heart failure risk prediction: the Cardiovascular Health Study Circ Heart Fail 3 2010 495 502
31. A. Goyal, C.R. Norton, T.N. Thomas Predictors of incident heart failure in a large insured population: a one million person-year follow-up study Circ Heart Fail 3 2010 698 705
32. C.S. Lam, A. Lyass, E. Kraigher-Krainer Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community Circulation 124 2011 24 30
33. R.T. Yan, D. Bluemke, A. Gomes Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 57 2011 1735 1744
34. C. Russo, Z. Jin, S. Homma Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort J Am Coll Cardiol 57 2011 1368 1374
35. Y. Wang, J. Tuomilehto, P. Jousilahti Occupational, commuting, and leisure-time physical activity in relation to heart failure among Finnish men and women J Am Coll Cardiol 56 2010 1140 1148
36. M.R. Shah, R.M. Califf, A. Nohria The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure J Card Fail 17 2011 613 621
37. L.W. Eurlings, P.E. van Pol, W.E. Kok Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can Pro-Brain-Natriuretic Peptide Guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?) study J Am Coll Cardiol 56 2010 2090 2100
38. J.T. Saunders, V. Nambi, J.A. de Lemos Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities study Circulation 123 2011 1367 1376
39. C.R. deFilippi, J.A. de Lemos, R.H. Christenson Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults JAMA 304 2010 2494 2502
40. R.S. Velagaleti, P. Gona, M.G. Larson Multimarker approach for the prediction of heart failure incidence in the community Circulation 122 2010 1700 1706
41. J.G. Smith, C. Newton-Cheh, P. Almgren Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation J Am Coll Cardiol 56 2010 1712 1719
42. E.A. Jankowska, P. Rozentryt, A. Witkowska Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J 31 2010 1872 1880
43. M.T. Maeder, O. Khammy, C. dos Remedios, D.M. Kaye Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure J Am Coll Cardiol 58 2011 474 480
44. H. Watkins, H. Ashrafian, C. Redwood Inherited cardiomyopathies N Engl J Med 364 2011 1643 1656
45. S. Waldmuller, J. Erdmann, P. Binner Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure Eur J Heart Fail 13 2011 1185 1192
46. W.F. Peacock, E. Braunwald, W. Abraham National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities J Am Coll Cardiol 56 2010 343 351
47. B.M. Massie, C.M. O'Connor, M. Metra Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
48. 1 Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) J Am Coll Cardiol 57 2011 1899 1907
49. G. Giamouzis, J. Butler, R.C. Starling Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) trial J Card Fail 16 2010 922 930
50. M. Bohm, K. Swedberg, M. Komajda Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
51. M. Guazzi, M. Vicenzi, R. Arena, M.D. Guazzi PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study Circ Heart Fail 4 2011 8 17
52. S. Nodari, M. Triggiani, U. Campia Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy J Am Coll Cardiol 57 2011 870 879
53. F. Iellamo, M. Volterrani, G. Caminiti Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study J Am Coll Cardiol 56 2010 1310 1316
54. 10 , rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (Controlled Rosuvastatin Multinational Study in Heart Failure) J Am Coll Cardiol 56 2010 1196 1204
55. G.J. Yoon, M.L. Telli, D.P. Kao, K.Y. Matsuda, R.W. Carlson, R.M. Witteles Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol 56 2010 1644 1650
56. H. Sawaya, I.A. Sebag, J.C. Plana Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
57. E.J. Velazquez, K.L. Lee, M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
58. R.O. Bonow, G. Maurer, K.L. Lee Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
59. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
60. D. Ferrante, S. Varini, A. Macchia Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up J Am Coll Cardiol 56 2010 372 378
61. S.I. Chaudhry, J.A. Mattera, J.P. Curtis Telemonitoring in patients with heart failure N Engl J Med 363 2010 2301 2309
62. F. Koehler, S. Winkler, M. Schieber Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study Circulation 123 2011 1873 1880
63. L.W. Stevenson, M. Zile, T.D. Bennett Chronic ambulatory intracardiac pressures and future heart failure events Circ Heart Fail 3 2010 580 587
64. E.Z. Gorodeski, E.C. Chu, C.H. Chow, W.C. Levy, E. Hsich, R.C. Starling Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee Circ Heart Fail 3 2010 706 714
65. A. Goda, L.H. Lund, D. Mancini The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy J Heart Lung Transplant 30 2011 315 325
66. R. John, F.D. Pagani, Y. Naka Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
67. J.N. Nativi, S.G. Drakos, A.Y. Kucheryavaya Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 30 2011 854 861
68. M. Singh, M. Shullo, R.L. Kormos Impact of renal function before mechanical circulatory support on posttransplant renal outcomes Ann Thorac Surg 91 2011 1348 1354
69. M.M. Kittleson, R. Shemin, J.K. Patel Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience J Heart Lung Transplant 30 2011 1018 1022
70. D.A. Baran, M.J. Zucker, L.H. Arroyo A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) trial Circ Heart Fail 4 2011 129 137
71. C. Kugler, D. Malehsa, U. Tegtbur Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study J Heart Lung Transplant 30 2011 204 210
72. R.C. Starling, Y. Naka, A.J. Boyle Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
73. S. Crow, D. Chen, C. Milano Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients Ann Thorac Surg 90 2010 1263 1269
74. N. Uriel, S.W. Pak, U.P. Jorde Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
75. J.M. Schaffer, J.G. Allen, E.S. Weiss Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation J Heart Lung Transplant 30 2011 164 174
76. J. Cowger, F.D. Pagani, J.W. Haft, M.A. Romano, K.D. Aaronson, T.J. Kolias The development of aortic insufficiency in left ventricular assist device-supported patients Circ Heart Fail 3 2010 668 674
77. A. Goda, H. Takayama, S.W. Pak Aortic valve procedures at the time of ventricular assist device placement Ann Thorac Surg 91 2011 750 754
78. V. Piacentino III, M.L. Williams, T. Depp Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices Ann Thorac Surg 91 2011 1342 1346
79. A.J. Boyle, D.D. Ascheim, M.J. Russo Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
80. R.M. Adamson, M. Stahovich, S. Chillcott Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience J Am Coll Cardiol 57 2011 2487 2495
81. E. Potapov, D. Meyer, M. Swaminathan Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial J Heart Lung Transplant 30 2011 870 878
82. E.J. Birks, R.S. George, M. Hedger Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 2011 381 390
83. S.S. Naidu Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support Circulation 123 2011 533 543
84. B. Kar, I.D. Gregoric, S.S. Basra, G.M. Idelchik, P. Loyalka The percutaneous ventricular assist device in severe refractory cardiogenic shock J Am Coll Cardiol 57 2011 688 696
85. J.D. Bisognano, G. Bakris, M.K. Nadim Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial J Am Coll Cardiol 58 2011 765 773
86. H. Krum, M. Schlaich, P. Sobotka, I. Scheffers, A.A. Kroon, P.W. de Leeuw Novel procedure- and device-based strategies in the management of systemic hypertension Eur Heart J 32 2011 537 544
87. G.M. De Ferrari, H.J. Crijns, M. Borggrefe Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure Eur Heart J 32 2011 847 855
88. M. Jessup, B. Greenberg, D. Mancini Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure Circulation 124 2011 304 313
89. J.P. Lassus, M.S. Nieminen, K. Peuhkurinen Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome Eur Heart J 31 2010 2791 2798
90. K. Damman, M.J. Ng Kam Chuen, R.J. MacFadyen Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function J Am Coll Cardiol 57 2011 2233 2241
91. S.M. Al-Khatib, A. Hellkamp, J. Curtis Non-evidence-based ICD implantations in the United States JAMA 305 2011 43 49
92. A.S. Fein, Y. Wang, J.P. Curtis, F.A. Masoudi, P.D. Varosy, M.R. Reynolds Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 56 2010 766 773
93. N.M. LaPointe, S.M. Al-Khatib, J.P. Piccini Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction Circ Cardiovasc Qual Outcomes 4 2011 146 151
94. G.H. Bardy, W.M. Smith, M.A. Hood An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
95. S. Adabag, H. Roukoz, I.S. Anand, A.J. Moss Cardiac resynchronization therapy in patients with minimal heart failure a systematic review and meta-analysis J Am Coll Cardiol 58 2011 935 941
96. F.A. McAlister, J. Ezekowitz, N. Hooton Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review JAMA 297 2007 2502 2514 (Pubitemid 46953404)
97. A. Arshad, A.J. Moss, E. Foster Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
98. S.D. Solomon, E. Foster, M. Bourgoun Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy Circulation 122 2010 985 992
99. A. Barsheshet, P.J. Wang, A.J. Moss Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) J Am Coll Cardiol 57 2011 2416 2423
100. K.C. Bilchick, S. Kamath, J.P. DiMarco, G.J. Stukenborg Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients Circulation 122 2010 2022 2030
101. V. Delgado, R.J. van Bommel, M. Bertini Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy Circulation 123 2011 70 78
102. J.P. Singh, H.U. Klein, D.T. Huang Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial Circulation 123 2011 1159 1166
103. F. Giraldi, G. Cattadori, M. Roberto Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy comparison of surgical versus hemodynamic procedure J Am Coll Cardiol 58 2011 483 490
104. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
105. M.T. Maeder, B.R. Thompson, H.P. Brunner-La Rocca, D.M. Kaye Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction J Am Coll Cardiol 56 2010 855 863
106. M. Kasner, D. Westermann, B. Lopez Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction J Am Coll Cardiol 57 2011 977 985
107. A. Deswal, P. Richardson, B. Bozkurt, D.L. Mann Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF) J Card Fail 17 2011 634 642
108. D.W. Kitzman, W.G. Hundley, P.H. Brubaker A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility Circ Heart Fail 3 2010 477 485
109. D.W. Kitzman, P.H. Brubaker, T.M. Morgan, K.P. Stewart, W.C. Little Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial Circ Heart Fail 3 2010 659 667
110. P.A. Heidenreich, A. Sahay, J.R. Kapoor, M.X. Pham, B. Massie Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006 J Am Coll Cardiol 56 2010 362 368
111. R.D. Kociol, B.G. Hammill, G.C. Fonarow Generalizability and longitudinal outcomes of a national heart failure clinical registry: comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries Am Heart J 160 2010 885 892
112. D.S. Lee, T.A. Stukel, P.C. Austin Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department Circulation 122 2010 1806 1814
113. G.C. Fonarow, N.M. Albert, A.B. Curtis Associations between outpatient heart failure process-of-care measures and mortality Circulation 123 2011 1601 1610
114. J.T. Heywood, G.C. Fonarow, C.W. Yancy Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF Circ Heart Fail 3 2010 596 605
115. K.E. Joynt, E.J. Orav, A.K. Jha The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure Ann Intern Med 154 2011 94 102
116. M. Jessup, N.M. Albert, D.E. Lanfear ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America J Am Coll Cardiol 57 2011 2115 2124
117. G.C. Fonarow, N.M. Albert, A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596